FOXA
34
-3
SEE
46
2
VLO
33
-2
NVDA
61
4
EW
38
-4
IP
33
3
AXP
74
-3
ADP
58
-4
PPG
64
3
ZBH
48
-2
PH
77
3
GILD
28
2
AVY
77
2
BEN
52
10
BAC
48
10
TSCO
66
11
DO
58
6
EMC
70
12
CMS
54
-6
AIZ
66
-2
FOXA
34
-3
SEE
46
2
VLO
33
-2
NVDA
61
4
EW
38
-4
IP
33
3
AXP
74
-3
ADP
58
-4
PPG
64
3
ZBH
48
-2
PH
77
3
GILD
28
2
AVY
77
2
BEN
52
10
BAC
48
10
TSCO
66
11
DO
58
6
EMC
70
12
CMS
54
-6
AIZ
66
-2
Financhill
Back

Y-mAbs Therapeutics Stock Predictions

Master the Market: The Formula for a 96.3% Win Rate Revealed!

Act now!
Buy
60

YMAB
Y-mAbs Therapeutics

Last Price:
14.68
Seasonality Move:
22.25%

7 Day Trial

ALL ACCESS PASS

$ 7

I love this overnight trade happening Thursday

Access my free presentation on these overnight trades right here

Y-mAbs Therapeutics Stock Forecast

  • Over the next 52 weeks, Y-mAbs Therapeutics has on average historically risen by 14.7% based on the past 5 years of stock performance.
  • Y-mAbs Therapeutics has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
  • Is Y-mAbs Therapeutics Stock Undervalued?
    The current Y-mAbs Therapeutics [YMAB] share price is $14.71. The Score for YMAB is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • YMAB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Y-mAbs Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Y-mAbs Therapeutics has on average historically risen by 14.7% based on the past 5 years of stock performance.

Y-mAbs Therapeutics Stock Rating

Buy
60
Y-mAbs Therapeutics (YMAB) is a Buy

Is Y-mAbs Therapeutics overpriced?

  • Y-mAbs Therapeutics has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%

Y-mAbs Therapeutics Stock Price History

Is YMAB stock going to rise?

  • The current trend is moderately bearish and YMAB is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
ymabs.com

52-Week Data

52-Week High:
20.90
52-Week Low:
4.60

Prediction Charts

Market Cap:
643.96M
Price in USD:
14.71
Volume:
189.35K
Beta:
0.82

Technical Analysis

SMA50:
15.74
SMA100:
12.46
SMA200:
9.01
52-Wk Change:
158.52%

Stock Predictions

  • Is Y-mAbs Therapeutics stock public?
    Yes, Y-mAbs Therapeutics is a publicly traded company.
  • What is the Y-mAbs Therapeutics stock quote today?
    The Y-mAbs Therapeutics stock price is 14.71 USD today.
  • How to buy Y-mAbs Therapeutics stock online?
    You can buy Y-mAbs Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-9 14.32 14.09 14.59 13.85
Apr-10 13.67 13.79 14.00 13.34
Apr-11 13.92 14.64 14.82 13.91
Apr-12 14.62 14.40 14.68 14.06
Apr-15 14.37 14.91 14.95 14.21
Apr-16 14.82 15.15 15.69 14.50
Apr-17 15.14 15.11 15.41 14.89
Apr-18 14.93 14.97 15.46 14.80
Apr-19 14.85 15.14 15.41 14.71
Apr-22 15.11 15.16 15.86 14.96
Apr-23 15.23 15.33 16.39 14.90
Apr-24 15.33 15.29 15.46 15.02
Apr-25 14.96 14.84 15.46 14.28
Apr-26 14.92 14.71 15.13 14.36

Y-mAbs Therapeutics Earnings

Y-mAbs Therapeutics Earnings Report: Per Share Y-mAbs Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Y-mAbs Therapeutics Forecast Revenue Growth

Y-mAbs Therapeutics Stock Analysis: Historical quarterly revenues per share for Y-mAbs Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.23 per share, and an increase next year of $0.27 per share.

* Y-mAbs Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.